Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'fluoxetine' OR with Authors including 'fluoxetine' OR with Abstract including 'fluoxetine' OR with Keywords including 'fluoxetine'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Gever MA, Dawsey WJ, Mand... Fading: A New Cytofluorimetric Measure Quantifying Serotonin in the P... J.Pharmacol.Exp.Ther... 1978
Kuhn DM, White FJ, Appel ... The Discriminative Stimulus Properties of LSD: Mechanisms of Action Neuropharmacology 1978
Aghajanian GK Psychotogenic Drug Action on Chemically Defined Neurons Psychopharmacol. Bul... 1979
Appel JB Neurohumoral Determinants of Sensitivity to LSD Psychopharmacol. Bul... 1979
Héry F, Simonnet G, Bourg... Effect Of Nerve Activity On The In Vivo Release Of [3H]serotonin Conti... Brain Research 1979
White FJ, Appel JB A Neuropharmacological Analysis of the Discriminative Stimulus Propert... Psychopharmacology 1981
Kleven MS, Dwoskin LP, Sp... Pharmacological Evidence for the Existence of Multiple Functional Pool... Journal of Neurochem... 1983
Monroe PJ, Smith DJ Characterization of Multiple [3H]5-Hydroxytryptamine Binding Sites in ... J. Neurochem. 1983
Schmidt CJ Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphet... J Pharmacol Exp Ther 1987
Nash JF Jr, Meltzer HY, G... Elevation of serum prolactin and corticosterone concentrations in the ... J Pharmacol Exp Ther 1988
Nichols DE, Oberlender R,... Studies of dioxole ring substituted 3,4-methylenedioxyamphetamine (MDA... Pharmacol Biochem Be... 1989
Sprouse JS, Bradberry CW,... MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal... Eur J Pharmacol 1989
Gessa GL [Guidelines for the drug therapy of alcoholism] Recenti Prog Med 1990
Azmitia EC, Murphy RB, Wh... MDMA (ecstasy) effects on cultured serotonergic neurons: evidence for ... Brain Res 1990
Callaway CW, Wing LL, Gey... Serotonin release contributes to the locomotor stimulant effects of 3,... J Pharmacol Exp Ther 1990
Fitzgerald JL, Reid JJ Effects of methylenedioxymethamphetamine on the release of monoamines ... Eur J Pharmacol 1990
McKenna DJ, Guan XM, Shul... 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential eff... Pharmacol Biochem Be... 1991
Callaway CW, Johnson MP, ... Amphetamine derivatives induce locomotor hyperactivity by acting as in... Psychopharmacology (... 1991
Dragunow M, Logan B, Lave... 3,4-Methylenedioxymethamphetamine induces Fos-like proteins in rat bas... Eur J Pharmacol 1991
Nash JF, Brodkin J Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dop... J Pharmacol Exp Ther 1991
Pan HS, Wang RY MDMA: further evidence that its action in the medial prefrontal cortex... Brain Res 1991
Berger UV, Gu XF, Azmitia... The substituted amphetamines 3,4-methylenedioxymethamphetamine, metham... Eur J Pharmacol 1992
Callaway CW, Geyer MA Stimulant effects of 3,4-methylenedioxymethamphetamine in the nucleus ... Eur J Pharmacol 1992
Kehne JH, McCloskey TC, T... Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (... J Pharmacol Exp Ther 1992
Strassman RJ Human hallucinogen interactions with drugs affecting serotonergic neur... Neuropsychopharmacol... 1992
Harvey JA, McMaster SE, R... Methylenedioxyamphetamine: Neurotoxic effects on serotonergic projecti... Brain Res 1993
Gu XF, Azmitia EC Integrative transporter-mediated release from cytoplasmic and vesicula... Eur J Pharmacol 1993
Hashimoto K, Maeda H, Hir... Drug effects on distribution of [3H]3,4-methylenedioxymethamphetamine ... Eur J Pharmacol 1993
Krebs KM, Geyer MA Behavioral characterization of alpha-ethyltryptamine, a tryptamine der... Psychopharmacology (... 1993
Rempel NL, Callaway CW, G... Serotonin1B receptor activation mimics behavioral effects of presynapt... Neuropsychopharmacol... 1993
Shiue CY, Shiue GG, Rysav... Fluorine-18 and carbon-11 labeled amphetamine analogs--synthesis, dist... Nucl Med Biol 1993
Leonardi ETK, Azmitia EC MDMA (ecstasy) inhibition of MAO type A and type B: comparisons with f... Neuropsychopharmacol... 1994
Marona-Lewicka D, Nichols... Behavioral effects of the highly selective serotonin releasing agent 5... Eur J Pharmacol 1994
Scheffel U, Dannals RF, S... Development of PET/SPECT ligands for the serotonin transporter NIDA Res Monogr 1994
Skop BP, Finkelstein JA, ... The serotonin syndrome associated with paroxetine, an over-the-counter... Am J Emerg Med 1994
Sprague JE, Nichols DE The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-meth... J Pharmacol Exp Ther 1995
Wichems CH, Hollingsworth... Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDM... Brain Res 1995
Gudelsky GA, Nash JF Carrier-mediated release of serotonin by 3,4-methylenedioxymethampheta... J Neurochem 1996
Malberg JE, Sabol KE, Sei... Co-administration of MDMA with drugs that protect against MDMA neuroto... J Pharmacol Exp Ther 1996
Obradovic T, Imel KM, Whi... Methylenedioxymethamphetamine-induced inhibition of neuronal firing in... Neuroscience 1996
Hanes KR Serotonin, psilocybin, and body dysmorphic disorder: a case report. J Clin Psychopharmac... 1996
Bonson KR, Buckholtz JW, ... Chronic administration of serotonergic antidepressants attenuates the ... Neuropsychopharmacol... 1996
Obradovic T, Imel KM, Whi... Methylenedioxymethamphetamine-induced inhibition of neuronal firing in... Neuroscience 1996
Martinez DL, Geyer MA Characterization of the disruptions of prepulse inhibition and habitua... Neuropsychopharmacol... 1997
Kramer HK, Poblete JC, Az... Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetam... Neuropsychopharmacol... 1997
Koch S, Galloway MP MDMA induced dopamine release in vivo: role of endogenous serotonin J Neural Transm 1997
Schechter MD Serotonergic mediation of fenfluramine discriminative stimuli in fawn-... Life Sci 1997
Aguirre N, Ballaz S, Lash... MDMA ('Ecstasy') enhances 5-HT1A receptor density and 8-OH-DPAT-induce... Eur J Pharmacol 1998
Byard RW, Gilbert J, Jame... Amphetamine derivative fatalities in South Australia--is 'Ecstasy' the... Am J Forensic Med Pa... 1998
Windhaber J, Maierhofer D... Panic disorder induced by large doses of 3,4-methylenedioxymethampheta... J Clin Psychopharmac... 1998
Kramer HK, Poblete JC, Az... Characterization of the translocation of protein kinase C (PKC) by 3,4... Neuropsychopharmacol... 1998
Shankaran M, Yamamoto BK,... Involvement of the serotonin transporter in the formation of hydroxyl ... Eur J Pharmacol 1999
Virden TB, Baker LE Disruption of the discriminative stimulus effects of S(+)-3,4-methylen... Behavioural Pharmaco... 1999
Mortensen OV, Kristensen ... Molecular cloning, expression and characterization of a bovine seroton... Brain Res Mol Brain ... 1999
Liaudet L, Buclin T, Jacc... Drug points: severe ergotism associated with interaction between riton... BMJ 1999
Edwards JG, Anderson I Systematic review and guide to selection of selective serotonin reupta... Drugs 1999
Winter JC, Helsley S, Fio... The acute effects of monoamine reuptake inhibitors on the stimulus eff... Pharmacol Biochem Be... 1999
Behan WMH, Madigan M, Cla... Muscle changes in the neuroleptic malignant syndrome J Clin Pathol 2000
Kalia M, O'Callaghan JP, ... Comparative study of fluoxetine, sibutramine, sertraline and dexfenflu... Brain Res 2000
Sanchez V, Camarero J, Es... The mechanisms involved in the long-lasting neuroprotective effect of ... Br J Pharmacol 2001
Aldurra G, Crayton JW Improvement of hallucinogen persisting perception disorder by treatmen... J Clin Psychopharmac... 2001
Oke A, Adhiyaman V, Aziz ... Dose-dependent seizure activity associated with fluoxetine therapy QJM 2001
O'Shea E, Esteban B, Cama... Effect of GBR 12909 and fluoxetine on the acute and long term changes ... Neuropharmacology 2001
Mamamoorthy Y, Tyndale R,... Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic a... Pharmacogenetics 2001
Mortensen OV, Kristensen ... Species-scanning mutagenesis of the serotonin transporter reveals resi... J Neurochem 2001
Ramamoorthy Y, Tyndale RF... Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic a... Pharmacogenetics 2001
Mechan AO, Esteban B, O'S... The pharmacology of the acute hyperthermic response that follows admin... Br J Pharmacol 2002
Whitworth TL, Herndon LC,... Psychostimulants differentially regulate serotonin transporter express... J Neurosci 2002
Ramamoorthy Y, Yu A, Suh ... Reduced (+/-)-3,4-methylenedioxymethamphetamine ('Ecstasy') metabolism... Biochem Pharmacol 2002
Fantegrossi WE, Godlewski... Pharmacological characterization of the effects of 3,4-methylenedioxym... Psychopharmacology (... 2003
Orio L, O'Shea E, Sanchez... 3,4-Methylenedioxymethamphetamine increases interleukin-1beta levels a... J Neurochem 2004
Meredith EJ, Holder MJ, C... The serotonin transporter (SLC6A4) is present in B-cell clones of dive... FASEB J 2005
Meredith EJ, Holder MJ, C... The serotonin transporter (SLC6A4) is present in B-cell clones of dive... FASEB J 2005
Navarro A, Perry C, Bobo ... A case of serotonin syndrome precipitated by abuse of the anticough re... Gen Hosp Psychiatry 2006
Saatcioglu O, Erim R, Cak... [A case of tianeptine abuse] Turk Psikiyatri Derg 2006
Escobedo I, Peraile I, Or... Evidence for a role of Hsp70 in the neuroprotection induced by heat sh... J Neurochem 2007
Wyman JF, Lavins ES, Enge... Postmortem Tissue Distribution of MDPV Following Lethal Intoxication b... J Anal Toxicol 2013
Benzer TI, Nejad SH, Floo... Case records of the Massachusetts General Hospital Case 40-2013A 36-ye... N Engl J Med 2013
Schoenfuss HL, Furlong ET... Complex mixtures, complex responses: Assessing pharmaceutical mixtures... Environ Toxicol Chem 2015
Dierksen J, Gonsoulin M, ... Poor Man's Methadone: A Case Report of Loperamide Toxicity Am J Forensic Med Pa... 2015